170 related articles for article (PubMed ID: 12916237)
21. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
Lin LF; Houng A; Reed GL
Biochemistry; 2000 Apr; 39(16):4740-5. PubMed ID: 10769130
[TBL] [Abstract][Full Text] [Related]
22. The β-domain of streptokinase affects several functionalities, including specific/proteolytic activity kinetics.
Rafipour M; Keramati M; Aslani MM; Arashkia A; Roohvand F
FEBS Open Bio; 2019 Jul; 9(7):1259-1269. PubMed ID: 31087538
[TBL] [Abstract][Full Text] [Related]
23. Structure-function analysis of the streptokinase amino terminus (residues 1-59).
Mundada LV; Prorok M; DeFord ME; Figuera M; Castellino FJ; Fay WP
J Biol Chem; 2003 Jul; 278(27):24421-7. PubMed ID: 12704199
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of the amino- and carboxyl-termini of streptokinase.
Fay WP; Bokka LV
Thromb Haemost; 1998 May; 79(5):985-91. PubMed ID: 9609234
[TBL] [Abstract][Full Text] [Related]
26. Resolution of conformational activation in the kinetic mechanism of plasminogen activation by streptokinase.
Boxrud PD; Verhamme IM; Bock PE
J Biol Chem; 2004 Aug; 279(35):36633-41. PubMed ID: 15215240
[TBL] [Abstract][Full Text] [Related]
27. Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.
Nihalani D; Raghava GP; Sahni G
Protein Sci; 1997 Jun; 6(6):1284-92. PubMed ID: 9194188
[TBL] [Abstract][Full Text] [Related]
28. Enhanced plasminogen activation by staphylokinase in the presence of streptokinase beta/betagamma domains: plasminogen kringles play a role.
Dahiya M; Rajamohan G; Dikshit KL
FEBS Lett; 2005 Mar; 579(7):1565-72. PubMed ID: 15757642
[TBL] [Abstract][Full Text] [Related]
29. Effect of fibrin degradation products on fibrinolytic process.
Yatsenko TA; Rybachuk VM; Yusova OI; Kharchenko SM; Grinenko TV
Ukr Biochem J; 2016; 88(2):16-24. PubMed ID: 29227597
[TBL] [Abstract][Full Text] [Related]
30. Streptokinase binds to human plasmin with high affinity, perturbs the plasmin active site, and induces expression of a substrate recognition exosite for plasminogen.
Boxrud PD; Fay WP; Bock PE
J Biol Chem; 2000 May; 275(19):14579-89. PubMed ID: 10799544
[TBL] [Abstract][Full Text] [Related]
31. [Covalent stretokinase-polyethylene glycol conjugates with increased stability and decreased side effects].
Aĭsina RB; Mukhametova LI; Tiupa DV; Gershkovich KB; Gulin DA; Varfolomeev SD
Bioorg Khim; 2014; 40(5):560-70. PubMed ID: 25895351
[TBL] [Abstract][Full Text] [Related]
32. A catalytic switch and the conversion of streptokinase to a fibrin-targeted plasminogen activator.
Reed GL; Houng AK; Liu L; Parhami-Seren B; Matsueda LH; Wang S; Hedstrom L
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8879-83. PubMed ID: 10430864
[TBL] [Abstract][Full Text] [Related]
33. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
Hunt JA; Petteway SR; Scuderi P; Novokhatny V
Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
[TBL] [Abstract][Full Text] [Related]
34. Plasmin inhibitors and fibrinogen breakdown during the initial phase of thrombolytic treatment--the problem of the alpha 2-antiplasmin determination.
Noll G; Lämmle B; Duckert F
Thromb Haemost; 1984 Jul; 51(3):334-7. PubMed ID: 6238441
[TBL] [Abstract][Full Text] [Related]
35. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
[TBL] [Abstract][Full Text] [Related]
36. Chimerism reveals a role for the streptokinase Beta -domain in nonproteolytic active site formation, substrate, and inhibitor interactions.
Gladysheva IP; Sazonova IY; Chowdhry SA; Liu L; Turner RB; Reed GL
J Biol Chem; 2002 Jul; 277(30):26846-51. PubMed ID: 12016220
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery.
Hermel M; Dailey W; Hartzer MK
Curr Eye Res; 2010 May; 35(5):419-24. PubMed ID: 20450255
[TBL] [Abstract][Full Text] [Related]
38. Skizzle is a novel plasminogen- and plasmin-binding protein from Streptococcus agalactiae that targets proteins of human fibrinolysis to promote plasmin generation.
Wiles KG; Panizzi P; Kroh HK; Bock PE
J Biol Chem; 2010 Jul; 285(27):21153-64. PubMed ID: 20435890
[TBL] [Abstract][Full Text] [Related]
39. Domain interactions between streptokinase and human plasminogen.
Loy JA; Lin X; Schenone M; Castellino FJ; Zhang XC; Tang J
Biochemistry; 2001 Dec; 40(48):14686-95. PubMed ID: 11724583
[TBL] [Abstract][Full Text] [Related]
40. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
